oxymetazoline has been researched along with Bilateral Headache in 3 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
Excerpt | Relevance | Reference |
---|---|---|
" Safety assessments included treatment-emergent adverse events (TEAEs) and posttreatment worsening of erythema (composite CEA/SSA increase of 1-grade severity from baseline; rebound effect)." | 6.87 | Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial. ( Ahluwalia, G; Berk, DR; Cook-Bolden, FE; Draelos, ZD; DuBois, J; Grande, K; Kircik, LH; Weng, E; Werschler, P, 2018) |
"Oxymetazoline is a sympathomimetic amine found in over-the-counter nasal decongestants." | 5.32 | Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray. ( Hill, MD; Hudon, ME; Loewen, AH, 2004) |
" Safety assessments included treatment-emergent adverse events (TEAEs) and posttreatment worsening of erythema (composite CEA/SSA increase of 1-grade severity from baseline; rebound effect)." | 2.87 | Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial. ( Ahluwalia, G; Berk, DR; Cook-Bolden, FE; Draelos, ZD; DuBois, J; Grande, K; Kircik, LH; Weng, E; Werschler, P, 2018) |
"Oxymetazoline is a sympathomimetic amine found in over-the-counter nasal decongestants." | 1.32 | Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray. ( Hill, MD; Hudon, ME; Loewen, AH, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kircik, LH | 1 |
DuBois, J | 1 |
Draelos, ZD | 1 |
Werschler, P | 1 |
Grande, K | 1 |
Cook-Bolden, FE | 1 |
Weng, E | 1 |
Berk, DR | 1 |
Ahluwalia, G | 1 |
Loewen, AH | 1 |
Hudon, ME | 1 |
Hill, MD | 1 |
Greene, RR | 1 |
1 trial available for oxymetazoline and Bilateral Headache
Article | Year |
---|---|
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Dermatitis; Double-Blind Method; Erythema | 2018 |
2 other studies available for oxymetazoline and Bilateral Headache
Article | Year |
---|---|
Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
Topics: Administration, Intranasal; Adult; Brain; Drug Administration Schedule; Female; Headache; Humans; Na | 2004 |
Clinical images: Afrin-induced central nervous system vasospasm and thunderclap headache.
Topics: Cerebral Angiography; Female; Headache; Humans; Middle Aged; Nasal Decongestants; Oxymetazoline; Vas | 2005 |